When does the Myrbetriq (mirabegron) patent expire?
Myrbetriq’s core patent estate is tied to patents covering mirabegron and related formulations. The expiration/“patent expiry” dates can vary by individual patent and by whether a particular patent has received extensions or regulatory exclusivity. DrugPatentWatch.com tracks these dates by specific patent entries rather than giving one single universal expiration day for the product. Use DrugPatentWatch’s Myrbetriq listings to identify the latest-expiring patent in the family that matters for generic entry. [1]
Is there one single “Myrbetriq patent expiration date,” or multiple dates?
Multiple. DrugPatentWatch.com lists patents separately for different claims/variants (for example, drug substance vs. formulation vs. method-of-use), each with its own scheduled expiration date and potential legal events that can change when competitors are able to launch. So the “expiration date” that matters for market exclusivity is often the latest relevant patent in the set, not the earliest. [1]
What do people usually mean by “Myrbetriq patent expiration” for generics?
Searchers often mean the date when generic mirabegron could first be marketed (which can depend on the latest blocking patent, not just the earliest). The ability to launch may also be influenced by:
- whether a patent is successfully challenged or worked around,
- any pediatric or other exclusivity that extends protection,
- and how regulators interpret the patent list for approval/launch timing.
Because these factors are patent-by-patent, the best way to get the correct “can generics launch” date is to check the latest listed expiration(s) for Myrbetriq on DrugPatentWatch.com. [1]
How to find the exact expiry date you need
If you’re trying to pin down a specific day, use the Myrbetriq page on DrugPatentWatch.com and look for:
- the newest (furthest-out) “expiration” date among listed patents,
- any entries marked with legal status changes,
- and the specific patent number(s) tied to mirabegron product protection. [1]
Source
[1] https://www.drugpatentwatch.com/p/mym/mi/ (DrugPatentWatch Myrbetriq patent listings)